Delirium in cardiovascular medicine - PubMed

2 days ago

Delirium is a common but underrecognized neuropsychiatric syndrome in cardiovascular medicine.
It is associated with prolonged hospitalization, increased mortality, and long-term cognitive decline.
Patients undergoing cardiovascular procedures like TAVR, CABG, or PCI are particularly vulnerable.
Risk factors include advanced age, cognitive impairment, cerebrovascular disease, and systemic inflammation.
Diagnostic tools like CAM and CAM-ICU are established but underutilized.
Non-pharmacological preventive strategies (e.g., early mobilization, sleep hygiene) are strongly supported.
Pharmacologic treatment is reserved for select cases (e.g., dexmedetomidine in ICU, cautious use of antipsychotics).
Delirium requires a proactive, interdisciplinary approach with systematic risk assessment and multimodal prevention.
Further high-quality studies are needed for evidence-based guidelines tailored to cardiovascular populations.

Hasty Briefsbeta